immunotherapy
HIV Antibody Therapy
HIV Antibody Therapy
Jef Akst | Apr 8, 2015
Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
Personalized Cancer Vaccines
Personalized Cancer Vaccines
Anna Azvolinsky | Apr 2, 2015
A dendritic cell vaccine targeting melanoma patients’ tumor-specific mutations can activate a broad range of cancer-fighting T cells. 
Yvonne Saenger: Immunotherapy Pioneer
Yvonne Saenger: Immunotherapy Pioneer
Jef Akst | Apr 1, 2015
Assistant Professor, Department of Medicine, Columbia University. Age: 41
The CAR T-Cell Race
The CAR T-Cell Race
Vicki Brower | Apr 1, 2015
Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.
Cancer Immunotherapist
Cancer Immunotherapist
Jef Akst | Apr 1, 2015
Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.
Opinion: Making Cancer Vaccines Work
Opinion: Making Cancer Vaccines Work
Abhishek Srivastava and Haval Shirwan | Mar 31, 2015
Armed with the right adjuvant system, vaccines are poised to tackle one of the world’s most intractable diseases. 
Long-Lived Immunotherapy Stem Cells
Long-Lived Immunotherapy Stem Cells
Ruth Williams | Feb 4, 2015
Genetically modified T memory stem cells persist in patients for more than 10 years, and can differentiate into a variety of T cell types.
FDA Gives Nod to Melanoma Drug
FDA Gives Nod to Melanoma Drug
Jef Akst | Sep 8, 2014
The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.
Week in Review: June 23–27
Week in Review: June 23–27
Tracy Vence | Jun 27, 2014
Tracking chikungunya virus; reconsidering wood decay-based fungal classification; ASC specks spread inflammation; antibiotic tolerance in E. coli; RIKEN review yields corrections